Article Details
Retrieved on: 2021-01-07 12:22:25
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The specialty biopharmaceutical company said the treatment is being developed as a potential first-line, stand-alone, oral treatment of pulmonary ...
Article found on: www.proactiveinvestors.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here